SSRIs抗抑郁剂联合黛力新治疗惊恐障碍的疗效观察

Observation of therapeutic effects of SSRIs and Deanxit in treatment of panic disorder

目的:探讨黛力新对于SSRIs抗抑郁剂治疗惊恐障碍的增效作用。方法:将符合CCMD-3诊断标准的30例惊恐障碍患者随机分为两组,SSRIs抗抑郁剂联合黛力新和单独使用SSRIs抗抑郁剂,治疗4周,根据疗效判定标准评定疗效。结果:联合黛立新组病例第一周全部见效。单用SSRIs抗抑郁剂药物治疗组第1周均无明显效果,第二周开始见效。4周后合并黛立新组痊愈率66.67%,单用SSRIs组痊愈率53.34%。结论:联合黛力新对于SSRIs抗抑郁剂治疗惊恐障碍有增效作用。

Objective：To discuss the synergistic effects of Deanxit to SSRIs on treating panic disorder.Methods：30 patients suffering from panic disorder met the diagnostic standard of CCMD-3 were divided into two groups.One group was treated by SSRIs and Deanxit and the another group was treated by SSRIs alone for four weeks.The efficacy was evaluated by the standard for treatment effect.Results：After one week of treatment,the combination treatment had the effects,while another group treated only by SSRIs had no obvious treatment effects.After four-week treatment,the cure rate was 66.67% in the combination treatment group and 53.34% in the single SSRIs group.Conclusion：Deanxit has the synergistic effects to SSRIs on treating panic disorder.